Mathé G, Diez-Condé M
Biomed Pharmacother. 1996;50(9):425-32. doi: 10.1016/s0753-3322(97)86001-5.
The authors describe the neoplasia of the only cell of the B-lymphocytic differentiation step, of which no lymphoma has yet been described: the cell intermediary between the memory B cell of the mantle zone, and the long-lived, marrow migrating and IgD or IgG secreting plasma cell, or mucosae migrating IgA secreting plasma-cell: they describe its neoplasia under the name of "medium cell cmu- sIg+ proplasmocytic lymphoma". It is defined by four characters: a) the homogeneous medium sized lymphoblastoid cells with one nucleolus per cell; b) the cmu- sIg+ marker as well as the CD38 and CD22; c) the t(11;14) translocation; and d) the poor prognosis and rapidly fatal evolution with a rapid conversion to the leukemic phase. The latter has probably been described, when the diagnosis is only made at this stage, as "B-prolymphocytic leukemia", which is nonsense, as the pre B-cells are cmu+ sIg-.
作者描述了B淋巴细胞分化过程中唯一一种尚未被描述为淋巴瘤的细胞的肿瘤形成:即介于套区记忆B细胞与长寿的、迁移至骨髓并分泌IgD或IgG的浆细胞,或迁移至黏膜并分泌IgA的浆细胞之间的中间细胞:他们将其肿瘤形成称为“中等细胞cmu-sIg+原浆细胞性淋巴瘤”。它由四个特征定义:a)大小均匀的中等大小淋巴母细胞样细胞,每个细胞有一个核仁;b)cmu-sIg+标志物以及CD38和CD22;c)t(11;14)易位;d)预后不良且迅速致命,迅速转化为白血病期。当仅在这个阶段做出诊断时,后者可能被描述为“B原淋巴细胞白血病”,这是无意义的,因为前B细胞是cmu+sIg-。